Prior Authorization for Three-Dimensional Versus Intensity-Modulated Radiotherapy Comparison Plans May Delay Treatment

Novák, Jakub; Germino, Elizabeth; Ivanov, Yu. V.; Vazquez, Joyce; Wohlers, Christopher; Kavanagh, Brian D.; Glaser, Scott; Amini, Arya

doi:10.1016/j.ijrobp.2020.07.2490

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In many instances, treating patients who have private insurance using IMRT requires prior-authorization, which can increase patient stress, delay treatment start, limit available physician time for direct patient care, and increase workload on departmental support staff. 16,17 Our analysis demonstrated that patients with Medicare and Medicaid insurance were more likely to receive IMRT for certain cancers than those with private insurance, perhaps due to challenges with prior authorization. Potentially modifiable factors warranting further investigation-e.g., inequitable denial of IMRT by insurance companies-were not ascertained in our data set yet could drive differences in IMRT .…”

Section: Discussionmentioning

confidence: 92%

Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy

Hutten

Weil

Gaffney

et al. 2022

Advances in Radiation Oncology

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract

Section: Discussionmentioning

confidence: 92%